|

DF1001 Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 1/2: 1

Top Sponsors

  • Dragonfly Therapeutics1

Indications

  • Solid Tumor, Adult1
  • Lung Cancer1
  • Breast Cancer1
  • Cancer1

Irvine, California1 trial

Study of DF1001 in Patients with Advanced Solid Tumors

University of California Irvine Medical Center

Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.